Results of the multi-center iPROMET study identify whole-body magnetic resonance imaging as a biomarker of response in prostate cancer patients…
Radiomics Group
Developed by VHIO’s Radiomics Group in close collaboration with researchers of the Neuro-Radiology Unit at the Bellvitge University Hospital (HUB),…
Reported today at the ESMO Congress 2023 in Madrid, results of a VHIO prospective study point to the promise of…
The VHIO Radiomics Group participates in this new European project On January 1, 2023, a new EU-funded research project establishing…
Researchers from the VHIO, promoted by the “la Caixa” Foundation, have verified in patients with advanced tumours that a new…
